Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.

Publisher:
BMC
Publication Type:
Journal Article
Citation:
Trials, 2024, 25, (1), pp. 350
Issue Date:
2024-05-30
Full metadata record
Please use this identifier to cite or link to this item: